Breaking News
Sort by:
Top Post
Novo Nordisk Receives Fda Approval of Higher-dose Ozempic® 2 Mg Providing Increased Glycemic Control for Adults With Type 2 Diabetes
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a […]
Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure
Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus digital […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution […]
US FDA Approves Jardiance ® (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction
The U.S. Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) 10 mg to […]
Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded […]
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently […]
Owkin and Amgen Use AI to Improve Cardiovascular Risk Prediction
AI startup Owkin and Amgen have announced the results of a three-year project to use […]
More People With Diabetes Set to Benefit From Blood Sugar Monitors as NHS Roll-Out Succeeds
Half of NHS Type 1 diabetes patients in England are now benefiting from the use […]
New Clot Busting Drug Could Improve Stroke Treatment
A new clot busting drug developed by scientists at the University of Manchester is able […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more